Owner Allergan, Inc.

Inventors Nguyen, Phong X.; Heidelbaugh, Todd M.; Chow, Ken

Agent Davies Collison Cave

Pub. Number AU-A-2009282017

PCT Pub. Number WO2010/019646

Priority 61/088,217 12.08.08 US

Filing date 12 August 2009

Wipo publication date 18 February 2010

C07C 233/66 (2006.01) Carboxylic acid amides

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 235/50 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 307/54 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom